The Valley Desk

NCT02931539 · Interventional trial

Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir

Overall registry status Completed

Phase 3

Conditions Cytomegalovirus (CMV)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov